Beverly, MA – United Kingdom based Applied Photophysics (APL) announced the grand opening of its new North American Demonstration Lab at Cummings Center in Beverly. The 2,400sf space is the global firm’s first North American location.
APL has also announced the launch of its qCD product series, which is designed to help develop novel biotherapeutics drugs.
APL develops and manufactures high performance modern spectrometry equipment for the life sciences industry. Established in 1971 by Lord George Porter and the Royal Institution of Great Britain, it is headquartered near London.
APL chose Beverly’s Cummings Center to be part of the strong biotech community on campus and in the region, according to David Gregson, CEO of Applied Photophysics. ”The number and variety of biotech and biopharma companies in Massachusetts made for a very compelling case: being close to so many potential customers is a real advantage,” he said.
“This new office and demonstration lab space will enable Applied Photophysics to make important contributions to the Massachusetts life sciences community, in the world’s leading ecosystem for life sciences innovation and growth,” said Mike Kennealy, acting president & CEO of the Massachusetts Life Sciences Center.
-more-
“Having a global firm like Applied Photophysics open in Beverly shows the international appeal of the growing biotech cluster on the North Shore,” said Senator Joan Lovely. “With APL’s opening and the support of the Massachusetts Life Sciences Center, the region and the Commonwealth continue to enhance their reputations as hubs for technology and innovation.”
“The Massachusetts life sciences ecosystem is crucial for fostering U.S. and UK ties to innovate research and therapies,” said Jeff Dillon, Vice Consul Trade & Investment Officer at the British Consulate General Boston. “We congratulate Applied Photophysics on the opening of its Demonstration Lab in Beverly.”